Free Trial Information
BioCentury | Sep 10, 2020
Finance

Sept. 9 Quick Takes: OncoImmune, Inversago raise B rounds; plus Trillium-Pfizer, Biofourmis, LinkDoc, Singleron, Hrain, InxMed and MilleporeSigma

...Fonds de solidarité FTQ and existing investors Genesys, JDRF T1D Fund, Amorchem, Anges Québec Capital, adMare BioInnovations...
Read More
BioCentury | Jun 11, 2020
Deals

June 10 Quick Takes: Lilly enters deal with Evox on exosome therapies; plus Sanofi-Alphamab, CSL-Vitaeris, Canbridge-UMass and Find’s debut

...airways, liver and gastrointestinal systems. The Montreal-based company has seed funding from CTI Life Sciences, adMare BioInnovations...
Read More
BioCentury | Jun 6, 2020
Product Development

June 5 Quick Takes: Merck, Tetraphase-Melinta, Apeiron, Neurasic, Jounce, Genmab-J&J

...a recombinant form of ACE2, to treat COVID-19. McGill spins out opioid-free pain management newco adMare BioInnovations...
Read More
BioCentury | Feb 8, 2020
Emerging Company Profile

Serentrix: pain relief without side effects

...cause hyperthermia or alter heat pain perception in Phase II. Neomed (now part of Canada’s adMare BioInnovations...
Read More
Items per page:
1 - 4 of 4
BioCentury | Sep 10, 2020
Finance

Sept. 9 Quick Takes: OncoImmune, Inversago raise B rounds; plus Trillium-Pfizer, Biofourmis, LinkDoc, Singleron, Hrain, InxMed and MilleporeSigma

...Fonds de solidarité FTQ and existing investors Genesys, JDRF T1D Fund, Amorchem, Anges Québec Capital, adMare BioInnovations...
Read More
BioCentury | Jun 11, 2020
Deals

June 10 Quick Takes: Lilly enters deal with Evox on exosome therapies; plus Sanofi-Alphamab, CSL-Vitaeris, Canbridge-UMass and Find’s debut

...airways, liver and gastrointestinal systems. The Montreal-based company has seed funding from CTI Life Sciences, adMare BioInnovations...
Read More
BioCentury | Jun 6, 2020
Product Development

June 5 Quick Takes: Merck, Tetraphase-Melinta, Apeiron, Neurasic, Jounce, Genmab-J&J

...a recombinant form of ACE2, to treat COVID-19. McGill spins out opioid-free pain management newco adMare BioInnovations...
Read More
BioCentury | Feb 8, 2020
Emerging Company Profile

Serentrix: pain relief without side effects

...cause hyperthermia or alter heat pain perception in Phase II. Neomed (now part of Canada’s adMare BioInnovations...
Read More
Items per page:
1 - 4 of 4